Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) is a leader in precision medicine with immuno-targeted products designed to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care. Applying our Manocept™ technology, Navidea seeks to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases, with an initial focus on personalized Rheumatoid Arthritis diagnostics. The company, founded in 1983, maintains headquarters in Dublin, Ohio.
Location: United States, Ohio, Dublin
Member count: 11-50
Phone: +1 614-793-7500
Total raised: $60M
Founded date: 1983
Investors 2
| Date | Name | Website |
| - | Hercules C... | htgc.com |
| - | CRG | crglp.com |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 14.05.2015 | - | $60M | - | massdevice... |
Mentions in press and media 10
| Date | Title | Description | Category | Author | Source |
| 04.02.2022 | Navidea Bi... | Navidea Biopharmaceuticals Ann... | - | - | marketscre... |
| 17.12.2021 | Navidea Bi... | Navidea Biopharmaceuticals Ter... | - | - | marketscre... |
| 10.12.2021 | Navidea Bi... | Navidea Biopharmaceuticals Ann... | - | - | marketscre... |
| 27.10.2021 | Navidea Bi... | Navidea Biopharmaceuticals Ann... | - | - | marketscre... |
| 20.09.2021 | Navidea Bi... | DUBLIN, Ohio - Navidea Biophar... | - | - | marketscre... |
| 17.09.2021 | Navidea Bi... | Navidea Biopharmaceuticals Ann... | - | - | marketscre... |
| 14.05.2015 | Navidea la... | Navidea (NYSE:NAVB) is getting... | - | Mark Hollm... | massdevice... |
| 22.08.2013 | Navidea’s ... | The presence of amyloid plaque... | - | - | medcitynew... |
| 13.03.2013 | Cancer: FD... | The FDA approved Navidea Bioph... | - | Arezu Sarv... | massdevice... |
| - | Navidea’s ... | Navidea Biopharmaceuticals (NY... | - | - | medcitynew... |